Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests

Sprache: Englisch

Verlag: National Academies Press, US, 2014

0309298210 / 9780309298216

Anbieter: Rarewaves USA United, HEBRON, KY, USARarewaves USA United

Verkäufer/-in mit 5 Sternen

Verkäufer:in bei ZVAB seit 20. Juni 2025

Softcover

Zustand: Neu

EUR 37,09

EUR 44,85 Versand 
Versand innerhalb von USA

Anzahl: 1 verfügbar

In den Warenkorb
30 Tage kostenlose Rückgabe

Artikelbeschreibung des Verkäufers

Many drug developers have examined new strategies for creating efficiencies in their development processes, including the adoption of genomics-based approaches. Genomic data can identify new drug targets for both common and rare diseases, can predict which patients are likely to respond to a specific treatment, and has the potential to significantly reduce the cost of clinical trials by reducing the number of patients that must be enrolled in order to demonstrate safety and efficacy. A key component of the approval of targeted therapeutics is the ability to identify the population of patients who will benefit from treatment, and this has largely hinged on the co-development and co-submission to the FDA of a companion diagnostic test.The co-development process, or the development of the test and drug for the simultaneous submission to FDA, has led to a major alteration in the way that drugs are being developed, with traditionally separate entities-pharmaceutical and diagnostic companies-now working in close collaboration.Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests is the summary of a workshop held by the Roundtable on Translating Genomic-Based Research for Health on February 27, 2013 to examine and discuss challenges and potential solutions for the codevelopment of targeted therapeutics and companion molecular tests for the prediction of drug response. Prior to the workshop, key stakeholders, including laboratory and medical professional societies, were individually asked to provide possible solutions to resolve the concerns raised about co-development of companion diagnostic tests and therapies. Workshop speakers were charged with addressing these solutions in their presentations by providing insight on (1) whether the proposed solutions address the problems described, (2) whether there are other solutions to propose, and (3) what steps could be taken to effectively implement the proposed solutions.…

Bestandsnummer des Verkäufers LU-9780309298216

Titel
Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests
Autor
Author Stated, No
Verlag
National Academies Press, US
Erscheinungsjahr
2014
Zustand
New
Einband
Paperback
Sprache
Englisch
ISBN-10
0309298210
ISBN-13
9780309298216

Rarewaves USA United

HEBRON, KY, USA

Verkäufer/-in mit 5 Sternen

Verkäufer:in bei ZVAB seit 20. Juni 2025

Versandkosten innerhalb von USA

Artikel30 bis 30 Werktage14 bis 14 Werktage
Erster ArtikelEUR 44,85EUR 60,10
Die Versandzeiten werden von den Verkäuferinnen und Verkäufern festgelegt. Sie variieren je nach Versanddienstleister und Standort. Sendungen, die den Zoll passieren, können Verzögerungen unterliegen. Eventuell anfallende Abgaben oder Gebühren sind von der Käuferin bzw. dem Käufer zu tragen. Die Verkäuferin bzw. der Verkäufer kann Sie bezüglich zusätzlicher Versandkosten kontaktieren, um einen möglichen Anstieg der Versandkosten für Ihre Artikel auszugleichen.

Zahlungsarten

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay

Unternehmensdaten der Verkäuferin bzw. des Verkäufers

Rarewaves USA

10100 West Sample Road, Ste 101
Coral Springs, FL USA 33065